← Back to Search

Early Palliative Care Consultation for Critical Illness

N/A
Waitlist Available
Led By Robert Zalenski, M.D., M.A.
Research Sponsored by Wayne State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Treated in a resuscitation room for unstable vital signs or respiratory compromise
Greater than or equal to 65 years old
Must not have
Lack decision capacity and have no relative available during ED stay to consent to the study (legally authorized representative-LAR)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Summary

This trial is studying whether it's better to have palliative care consultations in the emergency department or later on in the hospital.

Who is the study for?
This trial is for people aged 65 or older who are critically ill with conditions like advanced cancer, severe organ failure, sepsis, dementia, MS, Parkinson's disease or coma after cardiac arrest. They must be in emergency care for serious symptoms and not already enrolled in hospice care or have a do-not-resuscitate order.
What is being tested?
The study compares the timing of palliative care consultations: one group receives it early in the emergency department while the other gets it later during their ICU or hospital ward stay. Participants are randomly placed into these groups equally.
What are the potential side effects?
Since this trial involves palliative care consultation rather than medication, there aren't typical drug side effects. However, emotional distress or discomfort discussing end-of-life issues could occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I was treated in an emergency room for unstable vital signs or breathing problems.
Select...
I am 65 years old or older.
Select...
I have advanced cancer, severe organ failure, suspected sepsis, advanced dementia/MS/Parkinson's, or am in a coma after cardiac arrest.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot make decisions for myself and have no family to help during my emergency department stay.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Matches of care received to patient-specific preferences in Ig vs. Cg
Patient/family satisfaction with care in Ig vs. Cg
The proportion of billed CMS ACP-CPT codes in Ig vs. Cg

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Interventional group (Ig)Experimental Treatment1 Intervention
The interventional group (Ig) will have an early palliative care consultation ordered during their stay in the emergency department.
Group II: Control group (Cg)Active Control1 Intervention
The control group will be treated as standard of care. Palliative care consultations may or may not be ordered at the attending physician's discretion.

Find a Location

Who is running the clinical trial?

Wayne State UniversityLead Sponsor
312 Previous Clinical Trials
108,931 Total Patients Enrolled
Blue Cross Blue Shield of Michigan FoundationOTHER
27 Previous Clinical Trials
51,080 Total Patients Enrolled
Robert Zalenski, M.D., M.A.Principal InvestigatorWayne State University

Media Library

Early order of palliative care consultation Clinical Trial Eligibility Overview. Trial Name: NCT02858778 — N/A
Renal Disease Research Study Groups: Interventional group (Ig), Control group (Cg)
Renal Disease Clinical Trial 2023: Early order of palliative care consultation Highlights & Side Effects. Trial Name: NCT02858778 — N/A
Early order of palliative care consultation 2023 Treatment Timeline for Medical Study. Trial Name: NCT02858778 — N/A
~13 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top